{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:18:04Z","timestamp":1779164284391,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007586","name":"Aix-Marseille Universit\u00c3\u00a9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.pnpbp.2020.109927","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T14:03:43Z","timestamp":1584021823000},"page":"109927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort"],"prefix":"10.1016","volume":"101","author":[{"given":"G.","family":"Fond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Godin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Sch\u00fcrhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Berna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Aouizerate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Capdevielle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Chereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"D\u2019 Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dubertret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dubreucq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Faget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lan\u00e7on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Leignier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Misdrahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Passerieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Szoke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Urbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vidailhet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2020.109927_bb0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0920-9964(92)90003-N","article-title":"Reliability and validity of a depression rating scale for schizophrenics","volume":"6","author":"Addington","year":"1992","journal-title":"Schizophrenia research."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0010","series-title":"The scale to assess unawareness of mental disorder","author":"Amador","year":"1990"},{"key":"10.1016\/j.pnpbp.2020.109927_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2016.12.021","article-title":"Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort","volume":"185","author":"Andrianarisoa","year":"2017","journal-title":"Schizophr. Res."},{"issue":"1-2","key":"10.1016\/j.pnpbp.2020.109927_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0920-9964(02)00355-9","article-title":"Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL","volume":"63","author":"Auquier","year":"2003","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0025","first-page":"1","article-title":"Disparities in the management of cardiovascular risk factors in patients with psychiatric disorders: a systematic review and meta-analysis","author":"Ayerbe","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2016.04.042","article-title":"Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia","volume":"175","author":"Baudin","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2015.04.039","article-title":"Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia","author":"Belzeaux","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2015.10.040","article-title":"Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset","author":"Berna","year":"2015","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109927_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0447.1994.tb01487.x","article-title":"A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change","volume":"89","author":"Birchwood","year":"1994","journal-title":"Acta psychiatrica Scandinavica."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/08039488.2015.1086023","article-title":"Low levels of vitamin D poorly responsive to daylight exposure in patients with therapy-resistant schizophrenia","volume":"70","author":"Bogers","year":"2016","journal-title":"Nord J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","article-title":"The aggression questionnaire","volume":"63","author":"Buss","year":"1992","journal-title":"Journal of Personality and Social Psychology"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109927_bb0060","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.comppsych.2009.05.006","article-title":"An aid for diagnosing attention-deficit\/hyperactivity disorder at adulthood: psychometric properties of the French versions of two Wender Utah Rating Scales (WURS-25 and WURS-K)","volume":"51","author":"Caci","year":"2010","journal-title":"Comprehensive Psychiatr."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109927_bb0065","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3758\/BRM.40.2.563","article-title":"The three-factor model of Internet addiction: the development of the Problematic Internet Use Questionnaire","volume":"40","author":"Demetrovics","year":"2008","journal-title":"Behav. Res. Methods."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0070","author":"Dubreucq","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"11","key":"10.1016\/j.pnpbp.2020.109927_bb0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/070674370805301111","article-title":"The Beck Cognitive Insight Scale in outpatients with psychotic disorders: further evidence from a French-speaking sample","volume":"53","author":"Favrod","year":"2008","journal-title":"Can J Psychiatry."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0080","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2","author":"First","year":"1995"},{"key":"10.1016\/j.pnpbp.2020.109927_bb0085","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jad.2012.11.066","article-title":"Self-reported major depressive symptoms at baseline impact abstinence prognosis in smoking cessation program. A one-year prospective study","volume":"149","author":"Fond","year":"2013","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0090","article-title":"Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate","author":"Fond","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0095","article-title":"Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset","author":"Fond","year":"2015","journal-title":"Psychopharmacology (Berl.)."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0100","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/schbul\/sbv002","article-title":"The promise of biological markers for treatment response in first-episode psychosis: a systematic review","volume":"41","author":"Fond","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0105","article-title":"Benzodiazepine long-term administration is associated with impaired attention\/working memory in schizophrenia: results from the national multicentre FACE-SZ data set","author":"Fond","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0110","article-title":"Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset","author":"Fond","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2016.10.023","article-title":"Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset","volume":"182","author":"Fond","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0130","article-title":"Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort. Prog. Neuropsychopharmacol","author":"Fond","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0135","article-title":"Latent toxoplasma infection in real-world schizophrenia: results from the national FACE-SZ cohort","author":"Fond","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1192\/bjp.2018.87","article-title":"Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort","volume":"213","author":"Fond","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109927_bb0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pnpbp.2018.12.005","article-title":"Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort","volume":"92","author":"Fond","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109927_bb0160","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/S2468-2667(19)30187-2","article-title":"End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database","volume":"4","author":"Fond","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.pnpbp.2020.109927_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2015.07.047","article-title":"Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: results from the FACE-SZ cohort","author":"Godin","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpsychires.2017.06.008","article-title":"Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort","volume":"94","author":"Godin","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pnpbp.2019.01.003","article-title":"Validation and refinement of the clinical staging model in a French cohort of outpatient with schizophrenia (FACE-SZ)","volume":"92","author":"Godin","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2020.109927_bb0180","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"British J. Addict."},{"issue":"1-3","key":"10.1016\/j.pnpbp.2020.109927_bb0185","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jad.2010.11.013","article-title":"A French network of bipolar expert centres: a model to close the gap between evidence-based medicine and routine practice","volume":"131","author":"Henry","year":"2011","journal-title":"J Affect Disord."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0190","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/bdi.12539","article-title":"Outcomes for bipolar patients assessed in the French expert center network: A 2-year follow-up observational study (FondaMental Advanced Centers of Expertise for Bipolar Disorder [FACE-BD])","volume":"19","author":"Henry","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0195","first-page":"69","article-title":"Protective effects of quetiapine on metabolic and inflammatory abnormalities in schizophrenic patients during exacerbated stage","volume":"59","author":"Kao","year":"2016","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0200","article-title":"French adaptation of the Problematic Internet Use Questionnaire","author":"Kern","year":"2012","journal-title":"L'\u00e9volution psychiatrique"},{"key":"10.1016\/j.pnpbp.2020.109927_bb0205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.euroneuro.2017.11.020","article-title":"Factors associated with direct health care costs in schizophrenia: Results from the FACE-SZ French dataset","volume":"28","author":"Laidi","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109927_bb0210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-0447.1999.tb10851.x","article-title":"Validity and reliability of the French-language version of the Positive and Negative Syndrome Scale (PANSS)","volume":"100","author":"Lancon","year":"1999","journal-title":"Acta Psychiatrica Scandinavica."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109927_bb0215","first-page":"17","article-title":"Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms","volume":"19","author":"Lejoyeux","year":"1993","journal-title":"Encephale."},{"issue":"9","key":"10.1016\/j.pnpbp.2020.109927_bb0220","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1176\/ajp.144.9.1184","article-title":"The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers","volume":"144","author":"Lesieur","year":"1987","journal-title":"The American journal of psychiatry."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0225","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pnpbp.2017.06.026","article-title":"Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort","volume":"79","author":"Mallet","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0230","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pnpbp.2017.06.026","article-title":"Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort","volume":"79","author":"Mallet","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109927_bb0235","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/j.1440-1614.2006.01860.x","article-title":"Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions","volume":"40","author":"McGorry","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109927_bb0240","first-page":"409","article-title":"Therapeutic adherence and schizophrenia: the interest of the validation of the French translation of Medication Adherence Rating Scale (MARS)","volume":"30","author":"Misdrahi","year":"2004","journal-title":"L'Encephale."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0245","doi-asserted-by":"crossref","first-page":"e1130","DOI":"10.4088\/JCP.15m10115","article-title":"Determination of adherence profiles in schizophrenia using self-reported adherence: results from the FACE-SZ dataset","volume":"77","author":"Misdrahi","year":"2016","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0250","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12246","article-title":"Prevalence of and risk factors for extrapyramidal side effects of antipsychotics: results from the national FACE-SZ Cohort","volume":"80","author":"Misdrahi","year":"2019","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0255","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2014a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109927_bb0260","first-page":"335","article-title":"French version of the Yale-Brown Obsessive Compulsive Scale","volume":"15","author":"Mollard","year":"1989","journal-title":"L'Encephale."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0265","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1017\/S0950268813002756","article-title":"Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation","volume":"142","author":"Nogareda","year":"2014","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.comppsych.2016.11.006","article-title":"New evidence in support of staging approaches in schizophrenia: Differences in clinical profiles between first episode, early stage, and late stage","volume":"73","author":"Ortiz","year":"2017","journal-title":"Compr. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109927_bb0275","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7202\/008831ar","article-title":"Validation of the French version of the CTQ and prevalence of the history of maltreatment","volume":"29","author":"Paquette","year":"2004","journal-title":"Sante mentale au Quebec."},{"issue":"2-3","key":"10.1016\/j.pnpbp.2020.109927_bb0280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.schres.2004.02.019","article-title":"Measuring cognitive insight in middle-aged and older patients with psychotic disorders","volume":"71","author":"Pedrelli","year":"2004","journal-title":"Schizophrenia research."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0285","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2019.04.006","article-title":"Relationship between childhood trauma and level of insight in schizophrenia: A path-analysis in the national FACE-SZ dataset","volume":"208","author":"Pignon","year":"2019","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109927_bb0290","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1185\/030079904125003674","article-title":"Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients","volume":"20","author":"Prieto","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"issue":"8","key":"10.1016\/j.pnpbp.2020.109927_bb0295","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/070674371005500807","article-title":"French adaptation and validation of the scale to assess unawareness of mental disorder","volume":"55","author":"Raffard","year":"2010","journal-title":"Can J Psychiatry."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0300","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1192\/bjp.bp.108.060723","article-title":"Age at onset and cognition in schizophrenia: meta-analysis","volume":"195","author":"Rajji","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109927_bb0305","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-017-0779-9","article-title":"Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset","author":"Rey","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0310","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11638","article-title":"Mediation Analyses of Insight, Quality of Life, Depression, and Suicidality: results From the FACE-SZ Cohort","volume":"79","author":"Roux","year":"2018","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0315","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0269215518787324","article-title":"Screening for cognitive deficits with the Evaluation of Cognitive Processes involved in Disability in Schizophrenia scale","volume":"33","author":"Roux","year":"2019","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpsy.2015.05.004","article-title":"A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap","author":"Sch\u00fcrhoff","year":"2015","journal-title":"Eur. Psychiatry."},{"issue":"Pt 4","key":"10.1016\/j.pnpbp.2020.109927_bb0325","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1348\/014466502760387533","article-title":"The concurrent validity of the Global Assessment of Functioning (GAF)","volume":"41","author":"Startup","year":"2002","journal-title":"The British journal of clinical psychology \/ the British Psychological Society."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0330","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/j.pain.0000000000000304","article-title":"Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies","volume":"156","author":"Stubbs","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2020.109927_bb0335","doi-asserted-by":"crossref","DOI":"10.1111\/acps.12423","article-title":"Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis","author":"Sutterland","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109927_bb0340","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-3956(01)00052-8","article-title":"Validation of the behavioural activity rating scale (BARS): a novel measure of activity in agitated patients","volume":"36","author":"Swift","year":"2002","journal-title":"Journal of psychiatric research."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109927_bb0345","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/schbul\/sbn126","article-title":"Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology","volume":"35","author":"Whitty","year":"2009","journal-title":"Schizophr Bull."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0350","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"British J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2020.109927_bb0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1192\/bjp.bp.116.195776","article-title":"Cancer mortality in patients with schizophrenia: systematic review and meta-analysis","volume":"211","author":"Zhuo","year":"2017","journal-title":"Br. J. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619310905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619310905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:55:08Z","timestamp":1759521308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584619310905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":67,"alternative-id":["S0278584619310905"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109927","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109927"}}